New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr

Updated on: January 13,2024

New pancreatic cancer research could boost survival rates

byCU Anschutz Medical CampusGraphical abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.04.001A unique treatment combining radiation and immunotherapy can eradicate pancr

Updated on:January 13,2024

Five key medical advances related to bone marrow transplantation

by Heather Carlson Kehren,Mayo ClinicCredit: Mayo ClinicIn the six decades since blood and marrow transplantation was used to treat patients with blood cancers, this once experimental treatment

Updated on: January 30,2024

Five key medical advances related to bone marrow transplantation

by Heather Carlson Kehren,Mayo ClinicCredit: Mayo ClinicIn the six decades since blood and marrow transplantation was used to treat patients with blood cancers, this once experimental treatment

Updated on:January 30,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece

Updated on: December 25,2023

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece

Updated on:December 25,2023

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on: June 11,2024

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on:June 11,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on: January 07,2024

Team reports on development of potential new generic treatment for multiple types of cancer

byRIKENA schematic of the study. The simple targeted alpha-particle therapy (TAT) compound was made by joining the radionuclide astatine-211 to an azide. The TAT compound was injected into a mic

Updated on:January 07,2024

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on: December 18,2023

Fat fuels aggressive brain cancers

byCardiff UniversityGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Fat is powering tumour growth in brain cancer, finds

Updated on:December 18,2023

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress

Updated on: March 14,2024

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress

Updated on:March 14,2024

Signs there is a problem with your prostate

by Jason HowlandProstate cancer cells. Credit: NIH Image GalleryNovember is the time of the Movember movement, which encourages growing a mustache during the month to raise awareness of men's heal

Updated on: February 20,2024

Signs there is a problem with your prostate

by Jason HowlandProstate cancer cells. Credit: NIH Image GalleryNovember is the time of the Movember movement, which encourages growing a mustache during the month to raise awareness of men's heal

Updated on:February 20,2024

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on: December 23,2023

How optoacoustic imaging plays a role in assessing the success of breast cancer surgery

byAgency for Science, Technology and Research (A*STAR), SingaporeEquipment set-up. (A) Schematic of the handheld US-OT probe placed in heavy water tank on the specimen. The probe is then moved s

Updated on:December 23,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on: December 22,2023

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on:December 22,2023

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Updated on: May 06,2024

Investigating the most allergen-inducing drugs

by Scientific Project LomonosovComparison of % of spontaneous reports (SRs) with data on drug-induced anaphylaxis (SRsAs) due to a specific pharmacological group among the total SRsAs structure and %

Updated on:May 06,2024